Equities

Beijing Biostar Pharmaceuticals Co Ltd

Beijing Biostar Pharmaceuticals Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)28.70
  • Today's Change0.05 / 0.17%
  • Shares traded184.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 202320232022
ASSETS
Cash And Short Term Investments576729
Total Receivables, Net1639
Total Inventory2731
Prepaid expenses145.35
Other current assets, total----
Total current assets634805
Property, plant & equipment, net136118
Goodwill, net----
Intangibles, net1.632.83
Long term investments----
Note receivable - long term----
Other long term assets1.001.07
Total assets772926
LIABILITIES
Accounts payable2420
Accrued expenses1112
Notes payable/short-term debt00
Current portion long-term debt/capital leases0.731.09
Other current liabilities, total7.8319
Total current liabilities4452
Total long term debt0.170.81
Total debt0.901.90
Deferred income tax----
Minority interest----
Other liabilities, total5.275.88
Total liabilities4958
SHAREHOLDERS EQUITY
Common stock350350
Additional paid-in capital----
Retained earnings (accumulated deficit)374519
Treasury stock - common----
Unrealized gain (loss)----
Other equity, total(0.35)(0.83)
Total equity723868
Total liabilities & shareholders' equity772926
Total common shares outstanding365365
Treasury shares - common primary issue00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.